Literature DB >> 20736452

The requirement for NKG2D in NK cell-mediated rejection of parental bone marrow grafts is determined by MHC class I expressed by the graft recipient.

Joshua N Beilke1, Jonathan Benjamin, Lewis L Lanier.   

Abstract

Natural killer (NK) cells provide a unique barrier to semiallogeneic bone marrow (BM) transplantation. In the setting where the parents donate to the F1 offspring, rejection of parental bone marrow occurs. This "hybrid resistance" is completely NK cell dependent, as T cells in the F1 recipient tolerate parental grafts. Previously, we demonstrated that rejection of BALB/c parental BM by (BALB/c × C57BL/6) F1-recipient NK cells is dependent on the NKG2D-activating receptor, whereas rejection of parental C57BL/6 BM does not require NKG2D. BALB/c and B6 mice possess different NKG2D ligand genes and express these ligands differently on reconstituting BM cells. Herein, we show that the requirement for NKG2D in rejection depends on the major histocompatibility complex haplotype of donor cells and not the differences in the expression of NKG2D ligands. NKG2D stimulation of NK cell-mediated rejection was required to overcome inhibition induced by H-2D(d) when it engaged an inhibitory Ly49 receptor, whereas rejection of parental BM expressing the ligand, H-2K(b), did not require NKG2D. Thus, interactions between the inhibitory receptors on F1 NK cells and parental major histocompatibility complex class I ligands determine whether activation via NKG2D is required to achieve the threshold for rejection of parental BM grafts.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20736452      PMCID: PMC3012538          DOI: 10.1182/blood-2010-05-285031

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

1.  A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules.

Authors:  Nadine C Fernandez; Emmanuel Treiner; Russell E Vance; Amanda M Jamieson; Suzanne Lemieux; David H Raulet
Journal:  Blood       Date:  2005-02-22       Impact factor: 22.113

2.  Licensing of natural killer cells by host major histocompatibility complex class I molecules.

Authors:  Sungjin Kim; Jennifer Poursine-Laurent; Steven M Truscott; Lonnie Lybarger; Yun-Jeong Song; Liping Yang; Anthony R French; John B Sunwoo; Suzanne Lemieux; Ted H Hansen; Wayne M Yokoyama
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

3.  NK cells rapidly reject allogeneic bone marrow in the spleen through a perforin- and Ly49D-dependent, but NKG2D-independent mechanism.

Authors:  K Hamby; A Trexler; T C Pearson; C P Larsen; M R Rigby; L S Kean
Journal:  Am J Transplant       Date:  2007-08       Impact factor: 8.086

Review 4.  Enemy at the gates: forward genetics of the mouse antiviral response.

Authors:  Agnieszka Kielczewska; Silvia M Vidal
Journal:  Curr Opin Immunol       Date:  2006-08-01       Impact factor: 7.486

5.  Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts.

Authors:  Kouetsu Ogasawara; Jonathan Benjamin; Rayna Takaki; Joseph H Phillips; Lewis L Lanier
Journal:  Nat Immunol       Date:  2005-08-07       Impact factor: 25.606

6.  Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias.

Authors:  Pegah Nowbakht; Mihai-Constantin S Ionescu; Andreas Rohner; Christian P Kalberer; Emmanuel Rossy; Lucia Mori; David Cosman; Gennaro De Libero; Aleksandra Wodnar-Filipowicz
Journal:  Blood       Date:  2005-01-18       Impact factor: 22.113

7.  Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity.

Authors:  A Diefenbach; E R Jensen; A M Jamieson; D H Raulet
Journal:  Nature       Date:  2001-09-13       Impact factor: 49.962

8.  Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors.

Authors:  Hisashi Arase; Edward S Mocarski; Ann E Campbell; Ann B Hill; Lewis L Lanier
Journal:  Science       Date:  2002-04-11       Impact factor: 47.728

9.  Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.

Authors:  Loredana Ruggeri; Marusca Capanni; Elena Urbani; Katia Perruccio; Warren D Shlomchik; Antonella Tosti; Sabrina Posati; Daniela Rogaia; Francesco Frassoni; Franco Aversa; Massimo F Martelli; Andrea Velardi
Journal:  Science       Date:  2002-03-15       Impact factor: 47.728

10.  Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation.

Authors:  R M Sobecks; E J Ball; M Askar; K S Theil; L A Rybicki; D Thomas; S Brown; M Kalaycio; S Andresen; B Pohlman; R Dean; J Sweetenham; R Macklis; L Bernhard; K Cherni; E Copelan; J P Maciejewski; B J Bolwell
Journal:  Bone Marrow Transplant       Date:  2008-01-14       Impact factor: 5.483

View more
  11 in total

1.  NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT.

Authors:  Mobin A Karimi; Jerrod L Bryson; Lee P Richman; Andrew D Fesnak; Theresa M Leichner; Atsushi Satake; Robert H Vonderheide; David H Raulet; Ran Reshef; Taku Kambayashi
Journal:  Blood       Date:  2015-03-18       Impact factor: 22.113

2.  Antibody-drug conjugates plus Janus kinase inhibitors enable MHC-mismatched allogeneic hematopoietic stem cell transplantation.

Authors:  Stephen P Persaud; Julie K Ritchey; Sena Kim; Sora Lim; Peter G Ruminski; Matthew L Cooper; Michael P Rettig; Jaebok Choi; John F DiPersio
Journal:  J Clin Invest       Date:  2021-12-15       Impact factor: 14.808

3.  NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand.

Authors:  Gianfranco Pittari; Xiao-Rong Liu; Annamalai Selvakumar; Zeguo Zhao; Ernesto Merino; Morgan Huse; Joseph H Chewning; Katharine C Hsu; Bo Dupont
Journal:  J Immunol       Date:  2013-04-03       Impact factor: 5.422

Review 4.  NK cell recognition of hematopoietic cells by SLAM-SAP families.

Authors:  Shasha Chen; Zhongjun Dong
Journal:  Cell Mol Immunol       Date:  2019-03-25       Impact factor: 11.530

Review 5.  Unifying concepts of MHC-dependent natural killer cell education.

Authors:  Julie M Elliott; Wayne M Yokoyama
Journal:  Trends Immunol       Date:  2011-07-13       Impact factor: 16.687

6.  The natural killer cell activating receptor, NKG2D, is critical to antibody-dependent chronic rejection in heart transplantation.

Authors:  Christine M Lin; Ronald G Gill; Borna Mehrad
Journal:  Am J Transplant       Date:  2021-06-17       Impact factor: 9.369

Review 7.  The early days of NK cells: an example of how a phenomenon led to detection of a novel immune receptor system - lessons from a rat model.

Authors:  Bent Rolstad
Journal:  Front Immunol       Date:  2014-06-16       Impact factor: 7.561

8.  Minor Antigen Disparities Impede Induction of Long Lasting Chimerism and Tolerance through Bone Marrow Transplantation with Costimulation Blockade.

Authors:  Sinda Bigenzahn; Ines Pree; Christoph Klaus; Nina Pilat; Benedikt Mahr; Elisabeth Schwaiger; Patrick Nierlich; Friedrich Wrba; Thomas Wekerle
Journal:  J Immunol Res       Date:  2016-10-31       Impact factor: 4.818

9.  Risk of HLA Homozygous Cord Blood Transplantation: Implications for Induced Pluripotent Stem Cell Banking and Transplantation.

Authors:  Yasuo Morishima; Fumihiro Azuma; Koichi Kashiwase; Kayoko Matsumoto; Takeshi Orihara; Hiromasa Yabe; Shunichi Kato; Koji Kato; Shunro Kai; Tetsuo Mori; Kazunori Nakajima; Satoko Morishima; Masahiro Satake; Minoko Takanashi; Toshio Yabe
Journal:  Stem Cells Transl Med       Date:  2017-12-23       Impact factor: 6.940

Review 10.  Natural Killer Group 2, Member D/NKG2D Ligands in Hematopoietic Cell Transplantation.

Authors:  Raphael Carapito; Ismail Aouadi; Wassila Ilias; Seiamak Bahram
Journal:  Front Immunol       Date:  2017-03-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.